Toggle navigation
Home
Search
Services
Blog
Contact
About
Telomerase - Diagnostic/Prognostic Potential in Cancer
Kim, Nam W.
Geron Corporation, Menlo Park, CA, United States
Search 27 grants from Nam Kim
Search grants from Geron Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Inflammatory cascades disrupt Treg function through epigenetic mechanisms
Brain Tumors - Understanding and Control of Growth
DNA Replication by Satellite Phage P4 and Its Helper, P2
I-Corps: Fiber Scaffold Platform For 3D Cell Culture
AGEP: PEAKS: The Colorado Alliance for Graduate Education and the Professoriate
Recently added grants:
The role of nuclear PD-L1 in breast tumor cell division, progression and therapy response
Core A: Gastric Histopathology
Core B: Proteomics and Metabolomics
Intra- and inter-cellular signals that drive hepato-oncogenesis
The role of NFIB-MAST1 signaling in mediating adaptive cisplatin resistance in SCLC
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44CA067564-03
Application #
2748796
Study Section
Special Emphasis Panel (ZRG2-SSS-Y (14))
Program Officer
Couch, Jennifer A
Project Start
1995-04-14
Project End
1999-07-31
Budget Start
1998-08-01
Budget End
1999-07-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Geron Corporation
Department
Type
DUNS #
City
Menlo Park
State
CA
Country
United States
Zip Code
94025
Related projects
NIH 1998
R44 CA
Telomerase - Diagnostic/Prognostic Potential in Cancer
Kim, Nam W. / Geron Corporation
NIH 1997
R44 CA
Telomerase - Diagnostic/Prognostic Potential in Cancer
Kim, Nam W. / Geron Corporation
Publications
Frost, M; Bobak, J B; Gianani, R et al.
(2000)
Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix.
Am J Clin Pathol 114:726-34
Comments
Be the first to comment on this grant